• Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise

Log in

Start free trial
G2 Intelligence
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
Above-Market Lease with Landlord Doctors Costs BioReference $9.85 Million

Above-Market Lease with Landlord Doctors Costs BioReference $9.85 Million

by Glenn S. Demby | Jul 28, 2022 | Essential, Lab Compliance Advisor, Labs in Court-lca

In this month’s Labs in Court roundup, BioReference pays big to settle kickback allegations, among several other kickback-related cases.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Five Changes You Need to Know about New CLIA Proficiency Testing Rules

Five Changes You Need to Know about New CLIA Proficiency Testing Rules

by Glenn S. Demby | Jul 27, 2022 | CLIA-lca, Essential, Lab Compliance Advisor

With the final rule on PT published July 11, here are the five things lab managers need to know to keep their labs compliant.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Analytic Systems Account for 5 of Top 10 Most Cited CLIA Deficiencies

Analytic Systems Account for 5 of Top 10 Most Cited CLIA Deficiencies

by Glenn S. Demby | Apr 1, 2022 | Articles, CLIA-lca, Essential, Lab Compliance Advisor

CMS has published its list of top 10 most frequently cited Clinical Laboratory Improvement Amendments deficiencies for the previous year.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Fraud Trial of Theranos CEO Is Back on Track

Fraud Trial of Theranos CEO Is Back on Track

by Glenn S. Demby | Mar 22, 2022 | Articles, News, Open Content

After several delays, the trial of former Theranos CEO Ramesh “Sunny” Balwani on charges of fraud and wire fraud resumes today. The prosecution evidence includes records showing that Theranos voided lab test results to cure CLIA deficiencies cited in...
CMS Releases the Top 10 Lab CLIA Deficiencies for 2021

CMS Releases the Top 10 Lab CLIA Deficiencies for 2021

by Glenn S. Demby | Mar 14, 2022 | Articles, CLIA-nir, Essential, National Lab Reporter

...

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
« Older Entries
Next Entries »

Sign up for our free weekly Lab & Pathology Insider email newsletter

Log In

Join Now | Lost Password?
  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
Copyright © 2025 G2Intelligence.com